We are live on
!
Find out more
GCP
GSA Capital Partners Portfolio holdings
AUM
$1.59B
1-Year Est. Return
39.81%
This Fund
S&P 500
This Quarter
Est. Return
+14.21%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$987M
AUM Growth
+$120M
(+14%)
Cap. Flow
+$63.5M
Cap. Flow
% of AUM
6.44%
Top 10 Holdings %
Top 10 Hldgs %
5.22%
Holding
1,870
New
579
Increased
363
Reduced
419
Closed
480
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$6.71M |
| 2 |
DexCom
DXCM
|
+$6.59M |
| 3 |
X
US Steel
X
|
+$6.1M |
| 4 |
CMBT
CMB.TECH NV
CMBT
|
+$5.09M |
| 5 |
SPLK
Splunk Inc
SPLK
|
+$4.85M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GOOS
Canada Goose Holdings
GOOS
|
+$21.9M |
| 2 |
Constellation Brands
STZ
|
+$9.52M |
| 3 |
Lumen
LUMN
|
+$7.13M |
| 4 |
Weyerhaeuser
WY
|
+$6.3M |
| 5 |
FedEx
FDX
|
+$6.07M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.75% |
| 2 | Technology | 15.19% |
| 3 | Consumer Discretionary | 13.45% |
| 4 | Industrials | 12.06% |
| 5 | Financials | 9.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1126
Lamar Advertising Co
LAMR
$16.3B
| $242K | 0.02% |
+3,052
| New | +$231K |
|
1127
Park Hotels & Resorts
PK
$2.97B
| $242K | 0.02% |
+7,796
| New | +$233K |
|
1128
Universal Logistics Holdings
ULH
$529M
| $242K | 0.02% |
12,300
| – | – |
|
|
CATM
1129
DELISTED
Cardtronics plc Class A Ordinary Shares (UK)
CATM
| $242K | 0.02% |
6,815
-21,949
| -76% | -$654K |
|
|
ETFC
1130
DELISTED
E*Trade Financial Corporation
ETFC
| $241K | 0.02% |
5,187
-14,587
| -74% | -$694K |
|
1131
Twilio
TWLO
$36.6B
| $240K | 0.02% |
1,861
-634
| -25% | -$71.4K |
|
|
JNCE
1132
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $239K | 0.02% |
38,602
-93,498
| -71% | -$452K |
|
1133
Everest Group
EG
$14.4B
| $238K | 0.02% |
+1,101
| New | +$240K |
|
1134
Extreme Networks
EXTR
$3.15B
| $238K | 0.02% |
+31,798
| New | +$232K |
|
1135
Leidos
LDOS
$17.3B
| $238K | 0.02% |
+3,718
| New | +$224K |
|
1136
Entegris
ENTG
$23.2B
| $237K | 0.02% |
+6,639
| New | +$221K |
|
1137
SPDR Gold Trust
GLD
$141B
| $237K | 0.02% |
+1,940
| New | +$239K |
|
|
XLRN
1138
DELISTED
Acceleron Pharma
XLRN
| $237K | 0.02% |
+5,085
| New | +$223K |
|
|
BPL
1139
DELISTED
Buckeye Partners, L.P.
BPL
| $237K | 0.02% |
+6,980
| New | +$226K |
|
1140
Mattel
MAT
$4.23B
| $236K | 0.02% |
+18,157
| New | +$243K |
|
|
SRLP
1141
DELISTED
SPRAGUE RESOURCES LP
SRLP
| $236K | 0.02% |
12,745
-2,904
| -19% | -$50.6K |
|
|
BGG
1142
DELISTED
Briggs & Stratton Corp.
BGG
| $236K | 0.02% |
+19,919
| New | +$259K |
|
1143
Flowserve
FLS
$10.2B
| $235K | 0.02% |
5,209
-12,572
| -71% | -$549K |
|
1144
Raymond James Financial
RJF
$34B
| $235K | 0.02% |
+4,376
| New | +$234K |
|
|
ESV
1145
DELISTED
Ensco Rowan plc
ESV
| $235K | 0.02% |
14,942
-62,557
| -81% | -$1.09M |
|
1146
Employers Holdings
EIG
$889M
| $234K | 0.02% |
5,823
-11,254
| -66% | -$475K |
|
1147
MongoDB
MDB
$32.1B
| $233K | 0.02% |
+1,583
| New | +$162K |
|
|
I
1148
DELISTED
INTELSAT S. A.
I
| $233K | 0.02% |
14,900
| – | – |
|
1149
Boise Cascade
BCC
$3.02B
| $232K | 0.02% |
+8,678
| New | +$234K |
|
|
CLDR
1150
DELISTED
Cloudera, Inc.
CLDR
| $232K | 0.02% |
21,240
-12,847
| -38% | -$165K |
|
Similar funds
NCL
DG
VNT
SS
GWANC
LCM
LCM
FDCP
GSA Capital Partners's Q1 2019 Portfolio in Review
As of Q1 2019, GSA Capital Partners held 1,870 positions worth $987M, up 14% from $867M the previous quarter. Its ten largest holdings account for 5.2% of the portfolio.
GSA Capital Partners deployed $63.5M of net new capital in Q1 2019, opening 579 new positions and adding to 363 existing holdings. Its largest new stake was DexCom: 187,420 shares worth $5.58M.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Lumen, an estimated $7.13M trimmed.
- GSA Capital Partners's largest Q1 2019 buy was DexCom: 187,420 shares worth $5.58M.
- GSA Capital Partners added most to Biogen in Q1 2019, an estimated $6.71M increase.
- GSA Capital Partners's biggest Q1 2019 reduction was Lumen, cutting an estimated $7.13M.
- GSA Capital Partners fully exited Canada Goose Holdings in Q1 2019, selling an estimated $21.9M.
- GSA Capital Partners's ten largest holdings make up 5.2% of its $987M portfolio in Q1 2019.
- GSA Capital Partners opened 579 new positions and closed 480 in Q1 2019.
- GSA Capital Partners's portfolio value rose 14% quarter-over-quarter to $987M.
Based on GSA Capital Partners's 13F filing for Q1 2019, filed 15 May 2019.